Praxis Precision Medicines, Inc.
PRAX
$37.32
-$1.10-2.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 2,371.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 2,371.19% | |||
| Cost of Revenue | 8.03% | 34.40% | |||
| Gross Profit | -24.54% | -17.43% | |||
| SG&A Expenses | -7.99% | -0.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.63% | 25.00% | |||
| Operating Income | -16.84% | -12.53% | |||
| Income Before Tax | -18.09% | -13.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.09% | -13.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.09% | -13.04% | |||
| EBIT | -16.84% | -12.53% | |||
| EBITDA | -16.86% | -12.63% | |||
| EPS Basic | -12.06% | -6.84% | |||
| Normalized Basic EPS | -11.41% | -9.37% | |||
| EPS Diluted | -12.06% | -6.84% | |||
| Normalized Diluted EPS | -11.41% | -9.37% | |||
| Average Basic Shares Outstanding | 5.38% | 5.80% | |||
| Average Diluted Shares Outstanding | 5.38% | 5.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||